---
title: "Abridge lost AI scribing to Microsoft and Epic; its next market has a $100 million price from Wolters Kluwer"
description: "Microsoft and Epic took two of every three new AI-scribe dollars this year, and Abridge, which built that market, is selling what comes after the note. The decision-support category it is moving into just got a public price, Wolters Kluwer's $100 million AgileMD deal, and that price is what Abridge's $6.69 billion private mark has to outrun."
publisher: "The Inference"
section: "Health"
published: 2026-11-19T17:12:26.380Z
modified: 2026-11-19T17:12:26.380Z
canonical: https://theinference.org/article/abridge-lost-ai-scribing-to-microsoft-and-epic-its-next-market-has-a-100-million-price-from-wolters-kluwer
language: en
keywords: "Health, Artificial Intelligence, Clinical Decision Support, AI Scribes, Digital Health"
---

# Abridge lost AI scribing to Microsoft and Epic; its next market has a $100 million price from Wolters Kluwer

> Microsoft and Epic took two of every three new AI-scribe dollars this year, and Abridge, which built that market, is selling what comes after the note. The decision-support category it is moving into just got a public price, Wolters Kluwer's $100 million AgileMD deal, and that price is what Abridge's $6.69 billion private mark has to outrun.

[Abridge](https://theinference.org/markets/companies/abridge) created the market for AI medical scribes, and this year that market stopped being winnable: [Microsoft](https://theinference.org/markets/companies/microsoft) and Epic now capture about two of every three new scribe dollars [1][2]. Abridge's answer, announced at the HLTH conference in Las Vegas this week, is to sell what comes after the note; its clinical Assistant answered more than 40,000 questions from Department of Veterans Affairs clinicians last month [3].

The catch is the door it is running through. On November 13 the category it is escaping into got a public price, [Wolters Kluwer](https://theinference.org/markets/companies/wolters-kluwer)'s [$100 million deal for a 23-person decision-support firm](https://uk.finance.yahoo.com/news/wolters-kluwer-acquire-ai-powered-170000385.html), and that is the number [Abridge's $6.69 billion private valuation](https://theinference.org/article/abridge-carries-a-6-69-billion-mark-on-trials-showing-its-scribe-saves-22-minutes-a-day) has to outrun [4][5].

## The note became a feature of the record

Healthcare AI spending doubled to $3.7 billion this year, still the largest vertical market for AI [2]. Scribing grew far more slowly, because every major electronic health record now ships its own scribe, Microsoft's Dragon Copilot and Epic's Art among them, and the AI-native vendors that pioneered the category lost share [2][6]. A note is a byproduct of the record, so the record's owner wins on distribution; Menlo Ventures, which [surveyed 550 healthcare and life-sciences executives](https://finance.yahoo.com/healthcare/articles/menlo-ventures-2026-state-ai-113000492.html), calls pure note-taking largely commoditized [7].

*Chart: **Clinical copilots grew 5.5x in 2026 while ambient scribing grew 1.6x** Growth in 2026 US healthcare AI spending by category, with clinical copilots growing fastest and ambient scribing slowest*

*Year-over-year growth multiples in US healthcare AI spending by category, 2026, from Menlo Ventures' 2026 State of AI in Healthcare, a survey of 550 US healthcare and life-sciences executives. [2][6]*

## The Assistant sells the answer, not the note

What is new this week is scale in the layer above documentation. The Assistant reads the chart, runs the risk scores, drafts the handoff and answers clinical questions with citations, on infrastructure more than 300 health systems have already security-cleared [8][9]. Its new Local Pathways feature surfaces each health system's own care guidance, today buried in PDFs and intranets, beside the patient in front of the clinician [8], and [Wiley will license nearly 10,000 Cochrane systematic reviews](https://www.stocktitan.net/news/WLY/wiley-and-abridge-partner-to-bring-the-evidence-that-informs-09vurohnb1yc.html) into those answers [10].

Meeting every clinical guideline would take a primary care clinician a 27-hour workday, [one 2022 estimate found](https://medcitynews.com/2026/11/abridge-announcements-during-hlth-emphasize-growing-healthcare-trend/) [3]; the product bet is that the searching collapses into a question asked in place. Through the National Association of Community Health Centers, the Assistant also goes free to clinicians serving some 52 million people, many in rural areas, the deliberate counter to a divide this technology otherwise widens [3].

## The escape route is where the money already is

Wolters Kluwer, the Dutch publisher whose UpToDate reference tool is standard in US hospitals, agreed on November 13 to pay up to $100 million for [AgileMD](https://theinference.org/markets/companies/agilemd), a 23-person firm expected to book $7 million of annual revenue this year [4]. Its own copilot, UpToDate Expert AI, is already in more than 2,700 US hospitals [4]. An incumbent can buy into this category outright; Abridge has to earn it system by system, against [OpenEvidence](https://theinference.org/markets/companies/openevidence), the clinical copilot providers already choose most [1].

Below it, [OpenAI](https://theinference.org/markets/companies/openai) runs a prior-authorization task for 8.5 cents, [as we wrote on November 17](https://theinference.org/article/openai-prices-healthcare-back-office-work-at-8-5-cents-a-task-undercutting-ambience-healthcare) [5]. Abridge is building computer-use agents, which drive other software the way a person does, for applications with no API, alongside a Menlo-reported Availity deal for real-time prior authorization [1][11]; at CVS, [one such agent cleared a months-long document backlog over a weekend](https://www.fiercehealthcare.com/ai-and-machine-learning/hlth26-cvs-health-cigna-and-ambience-collaborating-openai-test-computer-use) [11].

## The clinician's question is what is left to own

The chain is short to state: models made the note cheap, the EHR bundled it, and what stays defensible is the trusted answer at the moment of care, wired to the chart, the published evidence and the system's own guidance. Abridge holds more of that wiring than anyone, and the VA numbers say clinicians already use it.

The note was always going to ship free with the record; the question in front of the patient was not. For listed readers, the first pricing arrives at Wolters Kluwer, where the deal closes by early 2027 and must earn back its cost of capital within five years [4].

## Takeaway

Microsoft and Epic took two of every three new AI-scribe dollars, and Wolters Kluwer just put the first public price on the category Abridge is escaping into: up to $100 million for a 23-person firm with $7 million of revenue. Abridge's $6.69 billion mark has to outrun that, one health system at a time.

## Sources

1. [Healthcare Dive, "Health AI spend doubles as providers invest in clinical copilots, front-office AI", 16 November 2026](https://www.healthcaredive.com/news/health-ai-spend-doubles-as-providers-invest-in-clinical-copilots-front-off/874752/)
2. [Menlo Ventures press release via Yahoo Finance, "Menlo Ventures' 2026 State of AI in Healthcare Report: Healthcare AI Spending Hits $3.7B, Up 2.5x", 16 November 2026](https://finance.yahoo.com/healthcare/articles/menlo-ventures-2026-state-ai-113000492.html)
3. [MedCity News, "Abridge Announcements during HLTH Emphasize Growing Healthcare Trend", November 2026](https://medcitynews.com/2026/11/abridge-announcements-during-hlth-emphasize-growing-healthcare-trend/)
4. [Wolters Kluwer press release via Yahoo Finance UK, "Wolters Kluwer to acquire AI-powered clinical decision support platform AgileMD", 13 November 2026](https://uk.finance.yahoo.com/news/wolters-kluwer-acquire-ai-powered-170000385.html)
5. [The Inference, "OpenAI prices healthcare back-office work at 8.5 cents a task, undercutting Ambience Healthcare", 17 November 2026](https://theinference.org/article/openai-prices-healthcare-back-office-work-at-8-5-cents-a-task-undercutting-ambience-healthcare)
6. [Becker's Hospital Review, "Healthcare AI spending jumps to $3.7B", 16 November 2026](https://www.beckershospitalreview.com/healthcare-information-technology/ai/healthcare-ai-spending-jumps-to-3-7b/)
7. [7wData, "Microsoft and Epic take 68% of new AI scribe spend as Abridge builds past the note", November 2026](https://7wdata.be/artificial-intelligence/microsoft-epic-ai-scribe-spend-abridge/)
8. [Abridge press release via KnowledgeNile, "With Local Pathways, the Abridge Assistant Cites a Health System's Own Guidance in Every Moment of Care", November 2026](https://www.knowledgenile.com/news-post/with-local-pathways-the-abridge-assistant-cites-a-health-systems-own-guidance-in-every-moment-of-care/)
9. [Abridge, "Abridge Assistant | Enterprise Clinical Decision Support", accessed 19 November 2026](https://www.abridge.com/platform/assistant)
10. [StockTitan (Business Wire), "Wiley and Abridge Partner to Bring the Evidence that Informs Clinical Guidelines Worldwide into the Abridge Assistant", 16 November 2026](https://www.stocktitan.net/news/WLY/wiley-and-abridge-partner-to-bring-the-evidence-that-informs-09vurohnb1yc.html)
11. [Fierce Healthcare, "HLTH 2026: CVS Health, Cigna and Abridge collaborating with OpenAI to test computer-use agents", 18 November 2026](https://www.fiercehealthcare.com/ai-and-machine-learning/hlth26-cvs-health-cigna-and-ambience-collaborating-openai-test-computer-use)


---

Abridge lost AI scribing to Microsoft and Epic; its next market has a $100 million price from Wolters Kluwer — The Inference. Canonical: https://theinference.org/article/abridge-lost-ai-scribing-to-microsoft-and-epic-its-next-market-has-a-100-million-price-from-wolters-kluwer
